Hanyang University Institute of Life Science and Technology transfers bio-sourced technology, expands faculty startups,
and Strategies for sustainable bio-convergence research, linkage with researchers, and education on technology used in
schools/industry We are working to build a bio-convergence research ecosystem.
HY-IBB aims to become a world-class life science convergence research group that leads the 4th industrial revolution and future
life science and leads technological innovation. Convergence research through cooperation among researchers within the school and research
cooperation with other universities and public research institutes, In particular, it aims to be quickly connected to commercialization
and industrialization of companies through cooperative research with the industry, and to be widely used in the field, such as hospitals.
We will strive to make HY-IBB a global think tank that contributes to our health and the development of the biohealth industry.
We are conducting various researches such as multi-omics-biometrics-personal health big data-based disease risk prediction original technology research.
We are conducting various researches such as precision medicine for cancer / immune / inflammatory diseases, original technology research for new drug development, and original technology research for eco-bio materials.
We are conducting various researches such as AI-based healthcare service development and source technology research for next-generation POCT molecular diagnosis development.
We are conducting various researches such as peptide/protein/antibody/cell-based biopharmaceutical candidates and original delivery technology research.
We are conducting various researches such as open lab, genome core, biological sample analysis core, BI computing core, and imaging core.